Regen BioPharma (RGBP) News Today → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free RGBP Stock Alerts 0.68 -0.02 (-2.86%) (As of 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRegen BioPharma (OTCMKTS:RGBP) Trading Up 23.3%americanbankingnews.com - April 19 at 2:38 AMPresenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Nowfinance.yahoo.com - April 3 at 7:34 AMRegen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024finance.yahoo.com - April 2 at 11:26 AMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024finance.yahoo.com - March 5 at 10:29 AMRGBPP Regen BioPharma, Inc. PFD SER A NEWseekingalpha.com - March 1 at 6:03 PMRegen BioPharma Stock (OTC:RGBP) Earnings Dates and Earning Callsbenzinga.com - February 25 at 2:34 PMRegen BioPharma Stock (OTC:RGBP), Short Interest Reportbenzinga.com - February 24 at 8:45 AMRegen Biopharma Files Patent for Blood Recovery Treatmentmsn.com - February 10 at 8:00 AMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024finance.yahoo.com - February 5 at 10:58 AMPresenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Nowfinance.yahoo.com - January 9 at 8:54 AMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024finance.yahoo.com - January 8 at 9:37 AMYeovil Refresh team asks for patience over town regenerationbbc.com - December 29 at 11:54 PMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023finance.yahoo.com - December 5 at 9:34 AMRegen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experimentsfinance.yahoo.com - November 16 at 1:27 PMRegen BioPharma, Inc. CEO Outlines Future Steps in CAR T Programfinance.yahoo.com - November 14 at 9:13 AMRegen BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023finance.yahoo.com - October 30 at 9:40 AMRegen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Programfinance.yahoo.com - October 25 at 1:44 PMRegen BioPharma, Inc. Expects Second Phase of Confirmatory Study Shortlyfinance.yahoo.com - October 18 at 1:12 PMRegen BioPharma, Inc. Receives First Phase of Confirmatory Studyfinance.yahoo.com - October 10 at 10:07 AMGoldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.finance.yahoo.com - October 4 at 9:43 AMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on October 5, 2023finance.yahoo.com - October 3 at 8:50 PMRegen BioPharma Inc. Non-Cum. Pfd. Series Abarrons.com - September 21 at 1:38 PMStudies On Regen BioPharma, Inc.'s DURACAR Indicate Potential Suppression Of Autoimmunity, Company Retains Contract Research Organization To Conduct Additional Confirmatory Studiesfinance.yahoo.com - September 19 at 1:46 PMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on September 6, 2023finance.yahoo.com - September 6 at 11:31 AMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on August 10, 2023finance.yahoo.com - August 8 at 2:25 PMCase study - urban regeneration in Stratford, Londonbbc.co.uk - March 23 at 9:22 AMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on March 3, 2023finance.yahoo.com - March 7 at 6:49 PMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on February 22, 2023finance.yahoo.com - February 21 at 2:04 PMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on February 8, 2023prnewswire.com - February 7 at 2:32 PMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on January 25, 2023prnewswire.com - January 23 at 3:17 PMRegen BioPharma Leverages Exosome Technologies to Broaden its Survivin Cancer Immunotherapy Portfoliofinance.yahoo.com - January 20 at 6:39 PMPresenting on the Emerging Growth Conference on January 11 Register Nowfinance.yahoo.com - January 10 at 7:59 AMRegen BioPharma, Inc. to address 2023 goals and company direction at the Emerging Growth Conference on January 11, 2023prnewswire.com - January 9 at 12:58 PMRegen BioPharma, Inc. issues Message to the Shareholders from the Chairman And Chief Executive Officerfinance.yahoo.com - December 19 at 5:22 PMRegen BioPharma Appoints Two New Scientific Advisory Board Membersfinance.yahoo.com - December 7 at 4:22 PMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on November 30, 2022finance.yahoo.com - November 28 at 7:29 PMRegen BioPharma, Inc. Progresses Its DuraCAR Therapeuticfinance.yahoo.com - November 18 at 9:37 AMRegen BioPharma Developing a Non-Exhaustible CAR-T Cell Therapeuticfinance.yahoo.com - November 10 at 8:13 PMRegen BioPharma, Inc. to Present at the Emerging Growth Conference on November 9, 2022finance.yahoo.com - November 2 at 8:05 PMRegen BioPharma, Inc. Explores the CAR-T Therapeutic Spacebenzinga.com - October 26 at 3:42 PMRegen BioPharma, Inc. Explores the CAR-T Therapeutic Spacefinance.yahoo.com - October 26 at 3:42 PMRegen BioPharma, Inc. Files Provisional Patent on CAR-T Cell Capable of Attracting and Educating Naive T Cells to Kill Cancermarketwatch.com - October 7 at 10:08 PMGeoff Fordham obituarytheguardian.com - October 6 at 11:05 AMRegen BioPharma, Inc. Files Provisional Patent on CAR-T Cell Capable of Attracting and Educating Naïve T Cells to Kill Cancerbenzinga.com - October 5 at 2:44 PMRegen BioPharma, Inc. Files Patent on Paradigm Shifting RNA/DNA-Based Approach to Cancer Immunotherapyfinance.yahoo.com - September 19 at 1:08 PMRGBP Regen BioPharma, Inc.seekingalpha.com - September 16 at 11:37 PMRegen BioPharma, Inc. Begins Experiments Validating Its Proprietary CAR-T Cell Therapyfinance.yahoo.com - September 13 at 5:06 PMRegen BioPharma, Inc. Begins Experiments Validating Its Proprietary CAR-T Cell Therapyfinance.yahoo.com - September 13 at 5:06 PMRegen BioPharma Develops Novel Means of Using CAR-T cell Immunotherapy to Attack Solid Tumorsfinance.yahoo.com - August 25 at 5:55 PMRegen BioPharma Increuters.com - August 12 at 12:00 AM Get Regen BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RGBP and its competitors with MarketBeat's FREE daily newsletter. Email Address The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about... Click here to see Louis' new video for yourself. RGBP Media Mentions By Week RGBP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGBP News Sentiment▼0.000.52▲Average Medical News Sentiment RGBP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGBP Articles This Week▼10▲RGBP Articles Average Week Get Regen BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RGBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Artelo Biosciences News Today Ascletis Pharma News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today BerGenBio ASA News Today BriaCell Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RGBP) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTiny Biotech Stock Wins $75 Billion PatentBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regen BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.